Nuclear receptors FXR and SHP regulate protein N-glycan modifications in the liver

Bhoomika Mathur, Asif Shajahan, Waqar Arif, Qiushi Chen, Nicholas J. Hand, Lara K. Abramowitz, Kristina Schoonjans, Daniel J. Rader, Auinash Kalsotra, John A. Hanover, Parastoo Azadi, Sayeepriyadarshini Anakk

Research output: Contribution to journalArticlepeer-review


Nuclear receptors farnesoid X receptor (FXR) and small heterodimer partner (SHP) are key regulators of metabo lism. Here, we report a previously unknown function for the hepatic FXR-SHP axis in controlling protein N-linked glycosylation. Transcriptome analysis in liver-specific Fxr-Shp double knockout (LDKO) livers revealed induction of genes encoding enzymes in the N-glycosylation pathway, including Mgat5, Fut8, St3gal6, and St6gal1. FXR ac tivation suppressed Mgat5, while Shp deletion induced St3gal6 and St6gal1. Increased percentages of core fucosylated and triantennary glycan moieties were seen in LDKO livers, and proteins with the "hyperglycoforms"preferentially localized to exosomes and lysosomes. This up-regulation of N-glycosylation machinery was specific to the Golgi apparatus and not the endoplasmic reticulum. The increased glycan complexity in the LDKO correlat ed well with dilated unstacked Golgi ribbons and alterations in the secretion of albumin, cholesterol, and tri glycerides. Our findings demonstrate a role for the FXR-SHP axis in maintaining glycoprotein diversity in the liver.

Original languageEnglish (US)
Article numbereabf4865
JournalScience Advances
Issue number17
StatePublished - Apr 21 2021

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Nuclear receptors FXR and SHP regulate protein N-glycan modifications in the liver'. Together they form a unique fingerprint.

Cite this